GLOBUS MEDICAL, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$5.30B
↑+1.0% +$51Mvs FY2024
Total Liabilities
$730M
↓-32.1% -$345Mvs FY2024
Equity
$4.57B
↑+9.5% +$396Mvs FY2024
Cash
$526M
↓-32.9% -$258Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $5.30B | $5.25B |
| Current Assets | $2.13B | $2.18B |
| Cash | $526M | $784M |
| ST Investments | $31M | $106M |
| Receivables | $679M | $558M |
| Inventory | $759M | $659M |
| Other Current | $130M | $70M |
| Non-Current Assets | $3.18B | $3.07B |
| PPE | $564M | $562M |
| Goodwill | $1.44B | $1.43B |
| Intangibles | $745M | $795M |
| Investments | $72M | $66M |
| Other Non-Current | $361M | $219M |
| Total Liab+Eq | $5.30B | $5.25B |
| Current Liab. | $498M | $856M |
| Accounts Payable | $99M | $75M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $28M | $22M |
| Other CL | $372M | $759M |
| Non-Current Liab. | $231M | $219M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $231M | $219M |
| Equity | $4.57B | $4.18B |
| Retained Earnings | $1.39B | $1.15B |
| Other Equity | $3.19B | $3.02B |
QuarterCharts · SEC EDGAR data · GMED · Comparing FY2025 vs FY2024